Answers are grounded in this paper and cite their sources.
Sponsorship of drug and device studies by the manufacturing company leads to more favorable efficacy results and conclusions than sponsorship by other sources. Our analyses suggest the existence of an industry bias that cannot be explained by standard 'Risk of bias' assessments.
No takes yet. Share an insight, caveat, or question.
Lundh et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: